Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Biological dehydrogenation preparation method of 6 alpha-methylprednisolone intermediate

A kind of intermediate and biological technology, which is applied in the field of preparation of steroidal drug intermediates, can solve the problems of differences in the production of dehydrogenates, no disclosure of strain preservation information, technical solutions that cannot be implemented, etc., to achieve the effect of avoiding residues and flexible selection

Active Publication Date: 2010-06-30
TIANJIN JINYAO GRP
View PDF1 Cites 32 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the technical solution disclosed in this application neither discloses any preservation information of the strains used for biological dehydrogenation, nor discloses the formula of the medium used for biological dehydrogenation. Because in the prior art, different bacterial strains and different mediums There is a big difference in the yield of producing dehydrogenate during production, which causes the technical scheme disclosed in this patent application to be unable to be implemented.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Biological dehydrogenation preparation method of 6 alpha-methylprednisolone intermediate
  • Biological dehydrogenation preparation method of 6 alpha-methylprednisolone intermediate
  • Biological dehydrogenation preparation method of 6 alpha-methylprednisolone intermediate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0049] Example 1: Using 11β, 17α-dihydroxy-pregna-4-ene-3,20-dione as a substrate;

[0050] Arthrobacter simplex (AS 1.94*) was subjected to slant culture, primary culture and secondary culture in sequence. The culture temperature was 31°C. The substrate dissolved in DMF was put into a 5L fermenter, the feeding concentration was 1%, and the reaction temperature was 31°C. The reaction time was 60 hours. After the reaction was completed, the temperature was raised to 70° C. to terminate the reaction. The fermentation broth was extracted with ethyl acetate, and the organic phase was concentrated. The conversion rate of the substrate was measured to be 73.5%.

Embodiment 2

[0051]Example 2: Using 17α, 21-dihydroxy-pregn-4-ene 3,11,20-triketone-21-acetate as the substrate;

[0052] Arthrobacter simplex (AS 1.94*) was subjected to slant culture, primary culture and secondary culture in sequence. The culture temperature was 32°C. The substrate dissolved in tetrahydrofuran was put into a 5L fermenter, the feeding concentration was 2%, and the reaction temperature was 32°C. The reaction time was 48 hours. After the reaction was completed, the temperature was raised to 70° C. to terminate the reaction. The fermentation broth was extracted with ethyl acetate, and the organic phase was concentrated. The conversion rate of the substrate was measured to be 77.3%.

Embodiment 3

[0053] Example 3: Using 11β, 17α, 21-trihydroxy-pregna-4-ene-3,20-dione-21-acetate as the substrate;

[0054] Arthrobacter simplex (AS 1.754) was subjected to slant culture, primary culture and secondary culture in sequence, and the culture temperature was 33°C. The substrate dissolved in dioxane was put into a 5L fermenter, and the feeding concentration was 1%, and the reaction The temperature was 33°C. The reaction time was 36 hours. After the reaction was completed, the temperature was raised to 70° C. to terminate the reaction. The fermentation broth was extracted with ethyl acetate, and the organic phase was concentrated. The conversion rate of the substrate was measured to be 81.6%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a biological dehydrogenation preparation method of a 6 alpha-methylprednisolone intermediate, which uses a compound of formula (1) as a substrate and obtains a compound of formula (2) by adopting a simple arthrobacterium biological dehydrogenation method. The process comprises the following steps of: crushing the formula (1) compound or dissolving the formula (1) compoundby using a solvent; adding to a fermentation tank with cultivated arthrobacterium to perform biotransformation; extracting, separating, and refining; drying, and then obtaining a dehydrogenation matter, i.e. the formula (2) compound. The invention can achieve the biotransformation rate of 70-90 percent.

Description

Technical field: [0001] The invention relates to a preparation method of a steroid drug intermediate, in particular to a method for preparing a pregnant drug intermediate through biological dehydrogenation. Background technique: [0002] 6α-methylprednisolone (methylprednisolone, CAS: 83-43-2; referred to as methylprednisolone) is a corticosteroid drug, it has anti-inflammatory, anti-endotoxin, immune suppression, anti-shock and other pharmacological effects, can Made into clinical injections, it has a very important role in clinical practice. The molecular formula is as follows: [0003] [0004] The 1,2-position dehydrogenation process is a key step in the production process of methylprednisolone, which directly affects the quality and yield of methylprednisolone. The dehydrogenation process in the prior art generally uses SeO 2 Dehydrogenation, SeO 2 It is a highly toxic substance, with large pollution, and the reaction yield is low, generally only 55%, the product...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12P33/02C12R1/06
Inventor 陈立营陈松赵琳
Owner TIANJIN JINYAO GRP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com